View All Immutep News. Immutep - Annual report to shareholders. 22 Oct 2024 01:10 PM. On behalf of the Board, I’m pleased to present Immutep Limiteds ...

Mr James David Walker (Executive Chairman, Executive Director) ...

Oct 2024 - Sky Network Television (ASX:SKT) has expanded its partnership with Warner Bros Discovery (WBD), announcing that it ...

Oct 2024 - The Dow Jones Industrial Average declined on Monday, giving back some of last week's strong gains as Treasury ...

Oct 2024 - A snapshot of the stocks on the move, featuring Nanoveu (ASX:NVU), MoneyMe (ASX:MME) and Alicanto Minerals (ASX:AQI).

Oct 2024 - Next Science Limited (ASX:NXS), a Sydney-based medical technology company, has reported a 7% dip in product sales for the third quarter of FY24, generating US$4.7 million.

Oct 2024 - Immutep (ASX:IMM) has made significant progress over the past year with its lead immunotherapy candidate, eftilagimod alpha (efti).

Oct 2024 - Australian semiconductor company BluGlass (ASX:BLG) has entered into a promising multi-phase Joint Development Agreement with Uviquity.

Oct 2024 - The company’s pipeline for SOZO units increased by 34%, with 28 units sold in the US, a notable rise from the previous quarter’s 23 units.

Volkswagen Finance has been fined £5.4 million by UK regulators after failing to treat customers fairly, according to a ruling by the UK’s Financial Conduct Authority.

Oct 2024 - Praemium Limited (ASX:PPS) reported a robust start to FY25, with total Funds Under Administration (FUA) increasing by 33% to $59.4 billion as of 30 September 2024.

Oct 2024 - Viva Energy (ASX:VEA) posted solid sales growth for the third quarter of 2024, with group sales volumes rising by 3% year-on-year to 4.2 billion litres.